Literature DB >> 19115210

Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer.

Thibaud Koessler1, Elizabeth M Azzato, Barbara Perkins, Robert J Macinnis, David Greenberg, Douglas F Easton, Paul D P Pharoah.   

Abstract

The mismatch repair (MMR) genes are involved in the maintenance of genomic integrity. Recently, we showed that common variants in these genes are unlikely to contribute significantly to colorectal cancer risk. The aim of this study was to investigate the role of common variants in the mismatch repair pathway as prognostic markers in colorectal cancer patients. We genotyped 2,060 patients for 68 SNPs in 7 mismatch repair genes (MLH1, MLH3, MSH2, MSH3, MSH6, PMS1 and PMS2), using a single nucleotide polymorphism (SNP) tagging approach. Genotypes at the tag SNPs and multi-SNP haplotypes were tested for association with overall survival (OS) and disease specific survival (DSS) using a Cox regression model. Eight SNPs and 10 haplotypes were significant at a nominal p < 0.05 in the univariate analyses. Stepwise analysis showed that haplotype effects were mainly due to associated SNPs carried by these haplotypes. After adjustment for sex, age at diagnosis and stage when using overall survival and stage only when using disease specific survival, prognostic values were unattenuated. The most significant SNP associated with disease specific survival after adjustment was rs863221, located in MSH3 (HR: 0.59, 95% confidence interval (CI) 0.42-0.82, p-value: 0.001). In conclusion, we find some evidence that common variants in mismatch repair genes may contribute to survival of patients with colorectal cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19115210     DOI: 10.1002/ijc.24120

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosis.

Authors:  Albert Tenesa; Evropi Theodoratou; Farhat V N Din; Susan M Farrington; Roseanne Cetnarskyj; Rebecca A Barnetson; Mary E Porteous; Harry Campbell; Malcolm G Dunlop
Journal:  Clin Cancer Res       Date:  2010-07-13       Impact factor: 12.531

Review 2.  Review: Single nucleotide polymorphisms associated with the oncogenesis of colorectal cancer.

Authors:  Koshi Mimori; Fumiaki Tanaka; Kohei Shibata; Masaki Mori
Journal:  Surg Today       Date:  2011-11-30       Impact factor: 2.549

3.  The prognostic significance of polymorphisms in hMLH1/hMSH2 for colorectal cancer.

Authors:  Yibaina Wang; Guangxiao Li; Fulan Hu; Haoran Bi; Zhiwei Wu; Xiaojuan Zhao; Ye Li; Shuying Li; Dandan Li; Binbin Cui; Xinshu Dong; Yashuang Zhao
Journal:  Med Oncol       Date:  2014-05-04       Impact factor: 3.064

4.  Overview of Research on Germline Genetic Variation in Immune Genes and Cancer Outcomes.

Authors:  Brittany N Chao; Danielle M Carrick; Kelly K Filipski; Stefanie A Nelson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-03-01       Impact factor: 4.090

5.  Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico.

Authors:  Wilfredo E De Jesus-Monge; Carmen Gonzalez-Keelan; Ronghua Zhao; Stanley R Hamilton; Miguel Rodriguez-Bigas; Marcia Cruz-Correa
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

6.  MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.

Authors:  Jee Hyun Park; Nung Soo Kim; Jae Yong Park; Yee Soo Chae; Jong Gwang Kim; Sang Kyun Sohn; Joon Ho Moon; Byung Woog Kang; Hun Mo Ryoo; Sung Hwa Bae; Gyu Seog Choi; Soo-Han Jun
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-21       Impact factor: 4.553

7.  CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.

Authors:  Ron Firestein; Kaori Shima; Katsuhiko Nosho; Natsumi Irahara; Yoshifumi Baba; Emeric Bojarski; Edward L Giovannucci; William C Hahn; Charles S Fuchs; Shuji Ogino
Journal:  Int J Cancer       Date:  2010-06-15       Impact factor: 7.396

8.  Association between colorectal cancer susceptibility loci and survival time after diagnosis with colorectal cancer.

Authors:  Amanda I Phipps; Polly A Newcomb; Xabier Garcia-Albeniz; Carolyn M Hutter; Emily White; Charles S Fuchs; Aditi Hazra; Shuji Ogino; Hongmei Nan; Jing Ma; Peter T Campbell; Jane C Figueiredo; Ulrike Peters; Andrew T Chan
Journal:  Gastroenterology       Date:  2012-05-08       Impact factor: 22.682

9.  Inactivation of MSH3 by promoter methylation correlates with primary tumor stage in nasopharyngeal carcinoma.

Authors:  Haifeng Ni; Bo Jiang; Zhen Zhou; Xiaoyang Yuan; Xiaolin Cao; Guangwu Huang; Yong Li
Journal:  Int J Mol Med       Date:  2017-06-27       Impact factor: 4.101

Review 10.  Germline Variants That Affect Tumor Progression.

Authors:  Ajay Chatrath; Aakrosh Ratan; Anindya Dutta
Journal:  Trends Genet       Date:  2020-11-14       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.